As of 2026-03-16, the Fair Value of Agios Pharmaceuticals Inc (AGIO) is -176.98 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 27.85 USD, the upside of Agios Pharmaceuticals Inc is -735.47%.
With the market price of 27.85 USD and our fair value calculation, Agios Pharmaceuticals Inc (AGIO) is not a good investment. Investing in Agios stocks now will result in a potential loss of 735.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 1,604.72 | -231.80 | -352.09 | 673.73 | -412.78 | 256.36 |
| YoY growth | 590.19% | -114.44% | -51.89% | 291.35% | -161.27% | 110.79% |
| Market Cap (mil) | 1,623.93 |
| P/E | |
| Forward P/E |
| EPS | -7.08 |
| Avg earnings growth rate | 110.79% |
| TTM earnings | -412.78 |